发明名称 PHARMACEUTICAL COMPOSITION ELICITING ANTITUMOR EFFECT WITH REDUCED ADVERSE EFFECTS AND CONTAINING ANTITUMOR AGENT AND DERIVATIVE OF HYDROXAMIC ACID
摘要 FIELD: medicine, oncology, pharmacy. SUBSTANCE: invention relates to pharmaceutical composition that shows the improved antitumor effect and reduced adverse effect(s). The composition comprises an active substance eliciting an antitumor effect or its pharmaceutically acceptable salt and derivative of hydroxamic acid by formula or therapeutically useful its acid additive salt. EFFECT: enhanced antitumor activity of composition. 10 cl, 10 tbl, 3 dwg
申请公布号 RU2214238(C2) 申请公布日期 2003.10.20
申请号 RU20000102359 申请日期 1998.06.22
申请人 N-GENE RISERCH LABORATORIZ INK. 发明人 SHUMEGI BALAZH
分类号 A61K45/00;A61K31/16;A61K31/282;A61K31/4545;A61K31/455;A61K45/06;A61P35/00;A61P35/04;A61P39/00;A61P43/00;F16K17/04;F16K37/00;(IPC1-7):A61K31/16 主分类号 A61K45/00
代理机构 代理人
主权项
地址